tiprankstipranks
Artivion (AORT)
NYSE:AORT
US Market

Artivion (AORT) Technical Analysis

Compare
363 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Artivion’s (AORT) Moving Averages Convergence Divergence (MACD) indicator is -0.25, suggesting Artivion is a Buy.
Artivion’s (AORT) 20-Day exponential moving average is 29.97, while Artivion’s (AORT) share price is $28.26, making it a Sell.
Artivion’s (AORT) 50-Day exponential moving average is 29.66, while Artivion’s (AORT) share price is $28.26, making it a Sell.

Artivion (AORT) Pivot Points

Feb 22, 2025, 08:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.27
27.71
28.27
28.71
29.26
29.70
30.26
Fibonacci
27.71
28.09
28.32
28.71
29.09
29.32
29.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Artivion (AORT) Moving Averages

Feb 22, 2025, 08:52 PM
Period
Simple
Exponential
MA5
29.27Sell
29.10Sell
MA10
29.79Sell
29.62Sell
MA20
30.42Sell
29.97Sell
MA50
29.74Sell
29.66Sell
MA100
28.54Sell
28.63Sell
MA200
26.79Buy
26.56Buy
Artivion’s (AORT) 10-Day exponential moving average is 29.62, while Artivion’s (AORT) share price is $28.26, making it a Sell.
Artivion’s (AORT) 100-Day exponential moving average is 28.63, while Artivion’s (AORT) share price is $28.26, making it a Sell.
Artivion’s (AORT) stock price is $28.26 and Artivion’s (AORT) 50-day simple moving average is 29.74, creating a Sell signal.
Artivion’s (AORT) stock price is $28.26 and Artivion’s (AORT) 100-day simple moving average is 28.54, creating a Sell signal.
Artivion’s (AORT) stock price is $28.26 and Artivion’s (AORT) 200-day simple moving average is 26.79, creating a Buy signal.

Artivion (AORT) Technical Indicators

Feb 22, 2025, 08:52 PM
Name
Value
Implied Action
RSI (14)
33.29
Neutral
STOCH (9,6)
15.74
Buy
STOCHRSI (14)
14.18
Buy
MACD (12,26)
-0.25
Buy
ADX (14)
21.53
Neutral
Williams %R
-95.22
Buy
CCI (14)
-186.70
Buy
ATR (14)
0.95
-
Ultimate Oscillator
46.46
Neutral
ROC
-8.72
Sell
Artivion’s (AORT) Relative Strength Index (RSI) is 33.29, creating a Neutral signal.
Artivion’s (AORT) Trend Strength Indicator (ADX) is 21.53, creating a Neutral signal.
Artivion’s (AORT) Commodity Channel Index (CCI) is -186.70, creating a Buy signal.
Artivion’s (AORT) Price Rate of Change (ROC) is -8.72, creating a Sell signal.

FAQ

Is AORT a Buy, Hold, or Sell?
Based on AORT’s technical indicators, AORT is a Sell.
    What is AORT’s RSI (14)?
    AORT’s RSI (14) is 33.29, which suggests AORT is a Neutral.
      What is AORT’s MACD?
      AORT’s MACD is -0.25, which suggests AORT is a Buy.
        What is AORT’s 5-day moving average?
        AORT’s 5-day moving average is 29.27, which suggests AORT is a Sell.
          What is AORT’s 20-day moving average?
          AORT 20-day moving average is 30.42, which suggests AORT is a Sell.
            What is AORT’s 50-day moving average?
            AORT’s 50-day moving average is 29.74, which suggests AORT is a Sell.
              What is AORT’s 200-day moving average?
              AORT’s 200-day moving average is 26.79, which suggests AORT is a Buy.
                What is AORT’s Williams % R (14)?
                AORT’s Williams % R (14) is -95.22, which suggests AORT is a Buy.
                  What is AORT’s CCI (14)?
                  AORT’s CCI (14) is -186.70, which suggests AORT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis